Atrium Therapeutics Inc (RNA)

Cost of Revenue

$343.00K

Quarterly · Period ending: · USD

RNA logo

RNA Cost of Revenue

Latest reported$343.00K
RNA Quarterly Cost of Revenue ($0.00 → $343.00K)
High-resolution chart · PNG

RNA cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
343,000
151,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.